NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 818 filers reported holding NOVARTIS A G in Q4 2013. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $7,692,471 | +0.2% | 76,186 | +1.0% | 0.04% | -10.4% |
Q3 2023 | $7,679,878 | +10.6% | 75,396 | +9.6% | 0.05% | 0.0% |
Q2 2023 | $6,943,138 | +21.0% | 68,805 | +10.3% | 0.05% | +14.3% |
Q1 2023 | $5,736,611 | +2.0% | 62,354 | +0.6% | 0.04% | -8.7% |
Q4 2022 | $5,623,604 | +101.1% | 61,989 | +68.5% | 0.05% | +31.4% |
Q3 2022 | $2,797,000 | -1.6% | 36,797 | +9.4% | 0.04% | -2.8% |
Q2 2022 | $2,842,000 | +9.5% | 33,624 | +13.7% | 0.04% | +12.5% |
Q1 2022 | $2,596,000 | +4.6% | 29,585 | +4.2% | 0.03% | +6.7% |
Q4 2021 | $2,483,000 | +8.1% | 28,389 | +1.1% | 0.03% | -3.2% |
Q3 2021 | $2,297,000 | -11.7% | 28,086 | -1.4% | 0.03% | -16.2% |
Q2 2021 | $2,600,000 | +295.1% | 28,491 | +270.0% | 0.04% | +164.3% |
Q1 2021 | $658,000 | -37.0% | 7,701 | -30.4% | 0.01% | -41.7% |
Q4 2020 | $1,045,000 | +4.0% | 11,071 | -4.2% | 0.02% | -7.7% |
Q3 2020 | $1,005,000 | -10.0% | 11,560 | -9.6% | 0.03% | -13.3% |
Q2 2020 | $1,117,000 | +4.8% | 12,789 | -1.0% | 0.03% | -14.3% |
Q1 2020 | $1,066,000 | -12.6% | 12,923 | +0.5% | 0.04% | +6.1% |
Q4 2019 | $1,220,000 | +11.5% | 12,862 | +2.4% | 0.03% | 0.0% |
Q3 2019 | $1,094,000 | -10.1% | 12,557 | -6.0% | 0.03% | -10.8% |
Q2 2019 | $1,217,000 | -3.7% | 13,363 | +1.6% | 0.04% | -9.8% |
Q1 2019 | $1,264,000 | +4.4% | 13,148 | -6.8% | 0.04% | -12.8% |
Q4 2018 | $1,211,000 | -8.5% | 14,100 | -8.1% | 0.05% | +2.2% |
Q3 2018 | $1,323,000 | +35.6% | 15,340 | +19.1% | 0.05% | -6.1% |
Q2 2018 | $976,000 | -4.7% | 12,881 | +1.6% | 0.05% | +8.9% |
Q1 2018 | $1,024,000 | +26.7% | 12,675 | +31.4% | 0.04% | +32.4% |
Q4 2017 | $808,000 | -7.3% | 9,646 | -4.4% | 0.03% | -15.0% |
Q3 2017 | $872,000 | +6.5% | 10,092 | +3.2% | 0.04% | +2.6% |
Q2 2017 | $819,000 | +11.9% | 9,782 | -0.9% | 0.04% | +11.4% |
Q1 2017 | $732,000 | +5.9% | 9,870 | +4.3% | 0.04% | -2.8% |
Q4 2016 | $691,000 | -39.6% | 9,465 | -34.7% | 0.04% | -18.2% |
Q3 2016 | $1,144,000 | +41.6% | 14,490 | +47.7% | 0.04% | -6.4% |
Q2 2016 | $808,000 | +3.3% | 9,808 | -9.2% | 0.05% | -4.1% |
Q1 2016 | $782,000 | -4.4% | 10,802 | +14.0% | 0.05% | -5.8% |
Q4 2015 | $818,000 | -14.6% | 9,479 | -9.3% | 0.05% | -20.0% |
Q3 2015 | $958,000 | -11.7% | 10,454 | -4.4% | 0.06% | -7.1% |
Q2 2015 | $1,085,000 | 0.0% | 10,930 | 0.0% | 0.07% | 0.0% |
Q1 2015 | $1,085,000 | -1.7% | 10,930 | -8.3% | 0.07% | -10.3% |
Q4 2014 | $1,104,000 | -6.9% | 11,914 | -5.9% | 0.08% | -3.7% |
Q3 2014 | $1,186,000 | -20.7% | 12,661 | -23.6% | 0.08% | -17.3% |
Q2 2014 | $1,496,000 | +10.5% | 16,574 | +4.9% | 0.10% | +1.0% |
Q1 2014 | $1,354,000 | +17.3% | 15,793 | +9.5% | 0.10% | +10.2% |
Q4 2013 | $1,154,000 | +7.0% | 14,420 | +3.0% | 0.09% | -5.4% |
Q3 2013 | $1,079,000 | +2.4% | 13,998 | -6.4% | 0.09% | -11.4% |
Q2 2013 | $1,054,000 | +1.4% | 14,948 | +2.0% | 0.10% | 0.0% |
Q1 2013 | $1,039,000 | – | 14,658 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 318,637 | $27,960,000 | 7.08% |
MANAGED ASSET PORTFOLIOS, LLC | 417,183 | $36,608,000 | 5.02% |
SAL Trading, LLC | 233,600 | $20,498,000 | 4.77% |
SCHARF INVESTMENTS, LLC | 1,340,680 | $117,662,000 | 3.49% |
SAL Trading, LLC | 155,783 | $13,670,000 | 3.18% |
First Fiduciary Investment Counsel, Inc. | 169,371 | $14,862,000 | 2.90% |
PRENTISS SMITH & CO INC | 55,026 | $4,829,000 | 2.90% |
GARLAND CAPITAL MANAGEMENT INC | 47,630 | $4,180,000 | 2.77% |
Cullen Capital Management, LLC | 3,295,271 | $289,160,000 | 2.66% |
WILKINS INVESTMENT COUNSEL INC | 133,880 | $11,748,000 | 2.65% |